ACRES Commercial Realty (ACR) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
12 May, 2026Executive summary
Closed $571 million in new loan commitments in Q4 2025, resulting in a net portfolio increase of $443.8 million after payoffs and unfunded commitments.
82% of the loan portfolio is multifamily-focused, with 96.8% of loans current on payments as of year-end.
Book value per share increased to $30.01 at December 31, 2025, up from $29.63 in 3Q25 and $28.87 in 4Q24.
Sold an REO office asset in Austin, TX, generating a $1.3 million EAD gain; charged off a legacy $4.7 million mezzanine loan fully reserved in 2022.
Originated $571 million in high-quality loans during Q4 2025, with origination momentum continuing into Q1 2026.
Financial highlights
GAAP net loss allocable to common shares was $3 million ($0.43 per share) for Q4 2025.
Net interest income rose by $2.3 million to $10.7 million compared to the prior quarter.
EAD for Q4 2025 was $0.20 per share excluding the mezzanine loan loss; including it, EAD loss was $0.48 per share.
GAAP book value per share increased to $30.01 from $29.63 sequentially.
CRE loan portfolio at par value was $1.8 billion, with $443.8 million in net loan fundings during Q4 2025.
Outlook and guidance
Projecting net portfolio growth of $500–$700 million in 2026.
Origination momentum expected to persist into 2026, with plans to provide loans to top sponsors in leading U.S. markets.
Illustrative earnings scenarios project EAD EPS between $0.47 and $2.93 depending on portfolio size and leverage, but these are not formal guidance.
Expecting $500 million in repayments in 2026, reducing older vintage assets to about 15% of the portfolio.
Anticipate portfolio mix to shift from heavy multifamily weighting to more diversified asset classes.
Latest events from ACRES Commercial Realty
- Internalization Merger and new equity plan proposed to enhance governance and align interests.ACR
Proxy filing11 May 2026 - Key votes include director elections, merger internalization, and new equity incentives.ACR
Proxy filing11 May 2026 - Q1 2026 featured a $3.3M real estate gain, $1B securitization, and a merger/internalization.ACR
Q1 20267 May 2026 - Stockholders to vote on internalization merger, new equity plan, and key governance proposals.ACR
Proxy filing1 May 2026 - Net income and book value rose, with 79% of loans in multifamily and strong liquidity.ACR
Q2 20242 Feb 2026 - Q3 2024 net income rose to $2.8M, book value per share hit $27.92, and liquidity stayed strong.ACR
Q3 202417 Jan 2026 - Q1 net loss, portfolio contraction, and new $939.9M facility amid elevated credit risk.ACR
Q1 202524 Dec 2025 - Book value and EAD rose on asset sales; strong multifamily loans and portfolio growth expected.ACR
Q4 202424 Dec 2025 - Annual meeting to vote on directors, Say on Pay, auditor, and highlight ESG and governance.ACR
Proxy Filing1 Dec 2025